{"schema_version":"secwatch.filing_event.v1","accession":"0001607062-24-000211","form_type":"8-K","ticker":"RGBP","cik":"0001589150","company_name":"Regen BioPharma Inc","filed_at":"2024-05-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.109628+00:00","generated_at":"2026-06-01T09:11:40.477617+00:00","sec_items":["5.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Regen Biopharma declares Series A Preferred stock dividend and amends charter","bullets":["On May 20, 2024, amended Certificate of Incorporation to allow share dividends between classes/series.","Board declared a dividend of 2 shares of Series A Preferred for each share of Common, Series A, AA, M, NC Preferred owned.","Record date: June 20, 2024; payment date: on or about July 1, 2024.","No ticker provided; company is an emerging growth company with no securities registered under Section 12(b)."],"urls":{"canonical":"https://secwatch.observer/filing/0001607062-24-000211","json":"https://secwatch.observer/filing/0001607062-24-000211.json","markdown":"https://secwatch.observer/filing/0001607062-24-000211.md","text":"https://secwatch.observer/filing/0001607062-24-000211.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1589150/000160706224000211/0001607062-24-000211-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1589150/000160706224000211/rgbp052224form8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T09:11:40.477617+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}